Intimate Partner Violence — The Hidden Burden Is Common

San Diego, May 16, 2006 – There is a chronic condition that as many as 44% of women have experienced. It adversely affects their physical and mental health. Screening for it is inadequate, and interventions are unclear. Two articles from Group Health Cooperative in Seattle and two commentaries in the June issue of the American Journal of Preventive Medicine examine intimate partner violence (IPV) and make recommendations for next steps in addressing this issue.

With colleagues from Harborview Injury Prevention and Research Center and the University of Washington, Group Health researchers evaluated the prevalence, timing, and severity of IPV in women, and the association between IPV and women’s health and health behaviors. 

In the first research article, Robert S. Thompson, MD, and colleagues found that IPV was not only highly prevalent (up to 44% of the more than 3,400 women said they experienced IPV as an adult) but also chronic, lasting more than 5 years and in some cases more than 20 years. Most abused women experienced more than one type of IPV: for example, physical IPV and verbal threats. In addition, the severity of abuse was rated as moderately or extremely violent in 30% to 60% of reports, depending on the type of IPV.

“A picture emerges of both physical and non-physical IPV as very common, chronic, intergenerational, and present in highly overlapping forms,” according to Thompson, senior investigator at Group Health Center for Health Studies. He and his coauthors conclude:

Amy E. Bonomi, PhD, MPH, research associate at Group Health Center for Health Studies, is the lead author of the second research article. She and her coauthors reported that rates of depression, physical symptoms, and social isolation were significantly higher in women who experienced IPV compared to women who never experienced IPV. Exposure to physical and/or sexual IPV in the past five years had the strongest adverse health effects for women. The longer women were exposed to IPV, the worse their health outcomes: This had not been shown before.

“In light of these findings and those from previous studies, it is critical to focus on strategies for the primary and secondary prevention of IPV that can be used not only in healthcare settings but also in other individual, community, and social arenas,” says Bonomi.

These findings provide “the additional challenge for us in the preventive medicine and public health communities to advocacy and action to prevent IPV,” Ann L. Coker, PhD, of the University of Texas Health Science Center, in Houston, writes in the accompanying editorial. “Identifying IPV and intervening to reduce the mental, physical, and social consequences of IPV must become a health priority so that providers can competently care for women, children, families, and communities.”

James S. Marks, MD, MPH, senior vice president of the Robert Wood Johnson Foundation, in Princeton, NJ, considers it unlikely that the 44% figure is an overestimate. “A primary challenge in studying IPV has been the understanding that prevalence rates likely underestimate this public health problem because of the stigma and shame associated with it,” he writes in his commentary introducing the two research articles.

The introductory article is “Does a Failure to Count Mean It Fails to Count? Addressing Intimate Partner Violence” by James S. Marks, MD, MPH, and Elaine F. Cassidy, PhD. The first article, on IPV incidence, is “Intimate Partner Violence—Prevalence, Types, and Chronicity in Adult Women” by Robert S. Thompson, MD; Amy E. Bonomi, PhD, MPH; Melissa Anderson, MS; Robert Reid, MD, PhD; Jane Dimer, MD; David Carrell, PhD; and Frederick P. Rivara, MD, MPH. The paper analyzing health effects is “Intimate Partner Violence and Women’s Physical, Mental, and Social Functioning” by Amy E. Bonomi, PhD, MPH; Robert S. Thompson, MD; Melissa Anderson, MS; Robert J. Reid, MD, PhD; David Carrell, PhD; Jane A. Dimer, MD; and Frederick P. Rivara, MD, MPH. The final article suggesting future efforts against IPV is “Preventing IPV: How We Will Rise to This Challenge” by Ann L. Coker, PhD. These appear in the American Journal of Preventive Medicine, Volume 30, Issue 6 (June 2006).

###

Full text of the articles is available upon request. Contact eajpm@ucsd.edu to obtain copies.

© 2006 American Journal of Preventive Medicine. All rights reserved. Unauthorized use prohibited.

About American Journal of Preventive Medicine
The American Journal of Preventive Medicine (  www.ajpm-online.net) is the official journal of The American College of Preventive Medicine (www.acpm.org) and The Association of Teachers of Preventive Medicine (  www.atpm.org). It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health. The journal features papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women's health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and alcohol and drug abuse. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. The journal also publishes official policy statements from the two co-sponsoring organizations, health services research pertinent to prevention and public health, review articles, media reviews, and editorials.

The American Journal of Preventive Medicine is ranked 9th out of 93 Public, Environmental & Occupational Health titles and 14th out of 103 General and Internal Medicine titles according to the Institute for Scientific Information's 2004 Journal Citation Reports.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact:
Charlotte Seidman,
Managing Editor
Phone: 858 457 7292
Email: eajpm@ucsd.edu